PerkinElmer Provides Update on Second Quarter Performance and Schedules Earnings Call for Wednesday, July 28, 2021
June 24 2021 - 6:00AM
Business Wire
Company anticipates 2Q21 revenue and earnings
to be above previously communicated guidance
PerkinElmer, Inc. (NYSE: PKI), a global leader committed to
innovating for a healthier world, today announced ahead of this
morning’s Virtual Investor and Analyst Day that it anticipates
exceeding its previously announced financial guidance for the
second quarter ending July 4, 2021, driven by broad-based momentum
across both COVID and non-COVID businesses.
Presentations from company executives for this morning’s
Investor and Analyst Day will begin at 8:30 a.m. ET and conclude at
approximately to 11:30 a.m. ET. All participants are requested to
register prior to the start of the event. The link can be accessed
on the Investors section of the Company’s website at
www.perkinelmer.com. A replay of the webcast will be available on
the PerkinElmer website following the presentation.
Additionally, PerkinElmer will release its second quarter 2021
financial results after market close on Wednesday, July 28, 2021.
The Company will host a conference call the same day at 5:00 p.m.
ET to discuss these results. Prahlad Singh, president and chief
executive officer, and Jamey Mock, senior vice president and chief
financial officer, will host the conference call.
To access the call, please dial (720) 405-2250 prior to the
scheduled conference call time and provide the access code 6596884.
A live audio webcast of the call will also be available on the
Investors section of the Company's website.
A replay of the webcast will be available beginning at 7:00 p.m.
ET, Wednesday, July 28, 2021 through the Investors section of the
Company’s website.
About PerkinElmer
PerkinElmer, Inc. is a global leader focused on innovating for a
healthier world. The Company reported revenue of approximately $3.8
billion in 2020, has more than 14,000 employees serving customers
in 190 countries, and is a component of the S&P 500 Index.
Additional information is available through 1-877-PKI-NYSE, or at
www.perkinelmer.com.
Factors Affecting Future Performance
This press release contains "forward-looking" statements within
the meaning of the Private Securities Litigation Reform Act of
1995, including, but not limited to, statements relating to
estimates and projections of future earnings per share, cash flow
and revenue growth and other financial results, developments
relating to our customers and end-markets, and plans concerning
business development opportunities, acquisitions and divestitures.
Words such as "believes," "intends," "anticipates," "plans,"
"expects," "projects," "forecasts," "will" and similar expressions,
and references to guidance, are intended to identify
forward-looking statements. Such statements are based on
management's current assumptions and expectations and no assurances
can be given that our assumptions or expectations will prove to be
correct. A number of important risk factors could cause actual
results to differ materially from the results described, implied or
projected in any forward-looking statements. These factors include,
without limitation: (1) markets into which we sell our products
declining or not growing as anticipated; (2) the effect of the
COVID-19 pandemic on our sales and operations; (3) fluctuations in
the global economic and political environments; (4) our failure to
introduce new products in a timely manner; (5) our ability to
execute acquisitions and license technologies, or to successfully
integrate acquired businesses and licensed technologies into our
existing business or to make them profitable, or successfully
divest businesses; (6) our ability to compete effectively; (7)
fluctuation in our quarterly operating results and our ability to
adjust our operations to address unexpected changes; (8)
significant disruption in third-party package delivery and
import/export services or significant increases in prices for those
services; (9) disruptions in the supply of raw materials and
supplies; (10) our ability to retain key personnel; (11)
significant disruption in our information technology systems, or
cybercrime; (12) our ability to realize the full value of our
intangible assets; (13) our failure to adequately protect our
intellectual property; (14) the loss of any of our licenses or
licensed rights; (15) the manufacture and sale of products exposing
us to product liability claims; (16) our failure to maintain
compliance with applicable government regulations; (17) regulatory
changes; (18) our failure to comply with healthcare industry
regulations; (19) economic, political and other risks associated
with foreign operations; (20) the United Kingdom’s withdrawal from
the European Union; (21) our ability to obtain future financing;
(22) restrictions in our credit agreements; (23) discontinuation or
replacement of LIBOR; (24) significant fluctuations in our stock
price; (25) reduction or elimination of dividends on our common
stock; and (26) other factors which we describe under the caption
"Risk Factors" in our most recent quarterly report on Form 10-Q and
in our other filings with the Securities and Exchange Commission.
We disclaim any intention or obligation to update any
forward-looking statements as a result of developments occurring
after the date of this press release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210624005053/en/
Investor Relations: Steve Willoughby (781) 663-5677
steve.willoughby@perkinelmer.com Media Relations: Chet
Murray (781) 663-5719 chet.murray@perkinelmer.com
PerkinElmer (NYSE:PKI)
Historical Stock Chart
From Aug 2024 to Sep 2024
PerkinElmer (NYSE:PKI)
Historical Stock Chart
From Sep 2023 to Sep 2024